Scientific Industries to Present at October 2020 Lytham Partners Virtual Investor Growth Conference

BOHEMIA, NY / ACCESSWIRE / October 6, 2020 / Scientific Industries, Inc. (OTCQB:SCND), a life science tool provider, is scheduled to participate in a virtual presentation and fireside chat at the October 2020 Lytham Partners Virtual Investor Growth Conference on Wednesday, October 7, 2020 at 4:00 p.m. ET (1:00 p.m. PT).

A webcast of the presentation will be posted under the investor relations section of Company’s website at https://www.scientificindustries.com/investor-relations/ and can be accessed at https://www.webcaster4.com/Webcast/Page/2521/37807 or www.lythampartners.com/virtual. A replay of the presentation will be available following the event.

Management will also be participating in virtual one-on-one meetings. To arrange a meeting, please contact Lytham Partners at 1×1@lythampartners.com or visit www.lythampartners.com/virtual.

About Scientific Industries

Scientific Industries is a life science tool provider. It designs, manufactures, and markets laboratory equipment, including the world-renowned Vortex-Genie® 2 Mixer and balances; customized catalyst research instruments and bioprocessing systems. Scientific Industries’ products are generally used and designed for research purposes in laboratories of universities, hospitals, pharmaceutical companies, and medical device manufacturers. Please visit www.scientificindustries.com.

About Scientific Bioprocessing Inc.

Scientific Bioprocessing develops manufactures and sells sensors and instruments for cell culture and bioprocessing. For more information please visit www.scientificbio.com.

Forward-Looking Statements

“Statements made in this press release and virtual investor conference that relate to future events, performance or financial results of the Company are forward-looking statements which involve uncertainties that could cause actual events, performance or results to materially differ. The Company undertakes no obligation to update any of these statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as to the date hereof. Accordingly, any forward-looking statement should be read in conjunction with the additional information about risks and uncertainties set forth in the Company’s Securities and Exchange Commission reports, including our annual report on Form 10-K.”

CONTACT:

Scientific Industries, Inc.

80 Orville Drive, Suite 102
Bohemia, New York 11716
Phone: (888) 850-6208 info@scientificindustries.com www.scientificindustries.com

SOURCE: Scientific Industries, Inc.

View source version on accesswire.com:
https://www.accesswire.com/609314/Scientific-Industries-to-Present-at-October-2020-Lytham-Partners-Virtual-Investor-Growth-Conference

Staff

Recent Posts

UOG (United One Group) Wins Three Prestigious Industry Awards at CES 2026

CES Official Spokesperson Highlights UOG Featured ProductsIntroducing the World's First Black Diamond Carbon & Nano…

6 hours ago

Best Ipamorelin vs Sermorelin: Growth Hormone Peptide Comparison 2026 — ReadyRx Prescription Telehealth Analysis

Independent research summary reviews mechanisms, regulatory considerations, and telehealth access pathways as consumers compare growth…

9 hours ago

GLP-1 Booster From Health Journey: 2026 Ingredient Analysis And Probiotic Metabolic Support Explained

Examining Akkermansia Muciniphila, Clostridium Butyricum, And The Gut Microbiome Research Behind This Probiotic GLP-1 Supplement…

9 hours ago

MEDVi GLP-1 Investigation: What Consumer Data Shows About Compounded Telehealth Weight Loss Programs

Independent Analysis Examines MEDVi's Semaglutide Medication Model, FDA Compounding Framework, and Prescription Accessibility Trends Heading…

9 hours ago

Best Peptides for Anti-Aging: NAD+ Delivery Methods Compared as Telehealth Platforms Expand Access (2026 Analysis)

Published NAD+ research examines cellular aging pathways and mitochondrial function as prescription peptide injection access…

9 hours ago

Foghorn Therapeutics Highlights January Equity Financing, Program Progress and Strategic Objectives for 2026

Recently raised $50 million with BVF Partners, Deerfield Management, founding investor Flagship Pioneering and a…

9 hours ago